Johnson & Johnson increases talc settlement by $1.1B, raising it to $9B over 25 years in response to cancer-related lawsuits.
Johnson & Johnson (J&J) plans to boost its talc settlement by $1.1 billion, raising the total to over $9 billion over 25 years to address lawsuits claiming its talc products caused cancer. The company is seeking to gain support from at least 75% of claimants to secure bankruptcy court approval. J&J, which maintains its products are safe, faces opposition from some attorneys who believe higher settlements could be obtained through litigation.
September 04, 2024
15 Articles